The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of oncology-advanced practitioners to enhance clinical research.
 
Christa Marie Braun-Inglis
No Relationships to Disclose
 
Leigh Boehmer
No Relationships to Disclose
 
Laura J Zitella
Consulting or Advisory Role - Daiichi Sankyo; Merck; Salix; Stemline Therapeutics
 
Brianna Hoffner
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Jessica Rhee
No Relationships to Disclose
 
Yurii B Shvetsov
No Relationships to Disclose
 
Randall A. Oyer
No Relationships to Disclose
 
Al Bowen Benson
Consulting or Advisory Role - Array BioPharma; Association for Value-Based Cancer Care (AVBCC); Bayer; Bristol-Myers Squibb; Dava Oncology; Genentech; Guardant Health; Harborside Press; LSK BioPharma; Merck Sharp & Dohme; Merck Sharp & Dohme; NCCN; Novartis; Pfizer; PrECOG; Research to Practice; Springer; TYME
Research Funding - Acerta Pharma/AstraZeneca (Inst); Advanced Accelerator Applications (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); ECOG-ACRIN (Inst); Infinity Pharmaceuticals (Inst); Infinity Pharmaceuticals (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); PrECOG (Inst); Rafael Pharmaceuticals (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Association of Community Cancer Centers (ACCC); Astellas Pharma; Bayer; Bristol-Myers Squibb; CancerCare; Genentech/Roche; Guardant Health; Lilly/ImClone; Lynx Group; Merck Sharp & Dohme; MJH Healthcare Holdings, LLC; NCCN; North American Neuroendocrine Tumor Society; NPAF/PAF